Typical Treatment Timeline During weeks one through four at the starter dose, most patients notice meaningful appetite reduction and faster feelings of fullness
Storage Store dry powder at 68F to 77F (20C to 25C) and away from heat, moisture and light
Any use outside legitimate scientific research is prohibited
CJC-1295, also referred to as Mod GRF 1-29, has been investigated as an analog of somatocrinin, with potential to stimulate growth hormone-releasing hormone (GHRH) receptors
Can be used with any medication or supplement
Despite correcting his severe B12 and iron deficiency with supplementation, this child remained delayed 7 months after treatment and upon MRI, still showed signs of inadequate myelination, suggesting that he may never achieve full neurological function